Abstract
Cancer-related anorexia/cachexia syndrome (CACS) is a complex phenomenon: metabolic abnormalities, proinflammatory cytokines produced by the host immune system, circulating tumor-derived catabolic factors, decreased food intake, and probably additional unknown factors, all play different roles. This review examines the pathophysiology and the mechanisms linking CACS and Oxidative Stress (OS) in cancer. On the basis of several of our previously published studies and our clinical experience we have developed an innovative treatment approach wich consists of an integrated nutritional and pharmacological treatment. This treatment approach of CACS/OS based on multiple components, each targeted at the different factors involved, may be effective both in improving objective clinical symptoms, including lean body mass, and subjective symptoms, including quality of life.
Keywords: Oxidative stress, cancer cachexia, Reactive Oxygen Species, antioxidant agents, innovative treatment approach, pharmaconutritional support.
Current Nutrition & Food Science
Title: Antioxidant Therapy for the Treatment of Oxidative Stress Associated to Cancer and Cancer- Related Anorexia/Cachexia
Volume: 3 Issue: 3
Author(s): Giovanni Mantovani, Clelia Madeddu, Antonio Maccio, Elena Massa, Giulia Gramignano and Roberto Serpe
Affiliation:
Keywords: Oxidative stress, cancer cachexia, Reactive Oxygen Species, antioxidant agents, innovative treatment approach, pharmaconutritional support.
Abstract: Cancer-related anorexia/cachexia syndrome (CACS) is a complex phenomenon: metabolic abnormalities, proinflammatory cytokines produced by the host immune system, circulating tumor-derived catabolic factors, decreased food intake, and probably additional unknown factors, all play different roles. This review examines the pathophysiology and the mechanisms linking CACS and Oxidative Stress (OS) in cancer. On the basis of several of our previously published studies and our clinical experience we have developed an innovative treatment approach wich consists of an integrated nutritional and pharmacological treatment. This treatment approach of CACS/OS based on multiple components, each targeted at the different factors involved, may be effective both in improving objective clinical symptoms, including lean body mass, and subjective symptoms, including quality of life.
Export Options
About this article
Cite this article as:
Giovanni Mantovani , Clelia Madeddu , Antonio Maccio , Elena Massa , Giulia Gramignano and Roberto Serpe , Antioxidant Therapy for the Treatment of Oxidative Stress Associated to Cancer and Cancer- Related Anorexia/Cachexia, Current Nutrition & Food Science 2007; 3 (3) . https://dx.doi.org/10.2174/157340107781369206
DOI https://dx.doi.org/10.2174/157340107781369206 |
Print ISSN 1573-4013 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3881 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardioprotective Effects of Sour Cherry Seed Extract (SCSE) on the Hypercholesterolemic Rabbit Heart
Current Pharmaceutical Design Editorial (Thematic Issue: Mitochondrial and Metabolism: Novel Targets for Heart Failure)
Current Pharmaceutical Design Imaging Subclinical Atherosclerosis: Where Do We Stand?
Current Cardiology Reviews Possible Hypoxia Signaling Induced Alteration of Glucose Homeostasis in Rats Exposed to Chronic Intermittent Hypoxia - Role of Antioxidant (Vitamin C) and Ca2+ Channel Blocker (Cilnidipine)
Current Signal Transduction Therapy Coumarin Compounds in Medicinal Chemistry: Some Important Examples from the Last Years
Current Topics in Medicinal Chemistry Neopterin: From Forgotten Biomarker to Leading Actor in Cardiovascular Pathophysiology
Current Vascular Pharmacology Long Chain Omega-3 Polyunsaturated Fatty Acids in Pediatric Metabolic Syndrome
Mini-Reviews in Medicinal Chemistry Catechol-O-Methyltransferase (COMT)-Mediated Methylation Metabolism of Endogenous Bioactive Catechols and Modulation by Endobiotics and Xenobiotics: Importance in Pathophysiology and Pathogenesis
Current Drug Metabolism Advanced In Silico Approaches for Drug Discovery: Mining Information from Multiple Biological and Chemical Data Through mtk- QSBER and pt-QSPR Strategies
Current Medicinal Chemistry Proinflammatory Cytokines and Sickness Behavior in Rheumatic Diseases
Current Pharmaceutical Design Potential Cardio-Protective Agents: A Resveratrol Review (2000-2019)
Current Pharmaceutical Design Reducing Perioperative Myocardial Infarction with Anesthetic Drugs and Techniques
Current Drug Targets Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Atrial Fibrillation and Chronic Kidney Disease in Hypertension: A Common and Dangerous Triad
Current Vascular Pharmacology Mass Spectrometry, Proteomics, Data Mining Strategies and Their Applications in Infectious Disease Research.
Anti-Infective Agents in Medicinal Chemistry The “Sympathetic” Kidney: Multiples Effects of Renal Sympathetic Nerve Ablation
Current Hypertension Reviews tPA in the Central Nervous System: Relations Between tPA and Cell Surface LRPs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Neurotoxicity by Synthetic Androgen Steroids: Oxidative Stress, Apoptosis, and Neuropathology: A Review
Current Neuropharmacology C-Reactive Protein and Atherosclerosis: An Update
Vascular Disease Prevention (Discontinued) Association between Paraoxonase 1(PON1) Gene Polymorphisms and PON1 Enzyme Activity in Indian Patients with Coronary Artery Disease (CAD)
Current Pharmacogenomics and Personalized Medicine